Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Aronia melanocarpa (black chokeberry) has garnered scientific interest for its potential role in managing elevated triglyceride levels. Several human clinical trials and animal studies suggest that supplementation with Aronia berry extracts or juice may have beneficial effects on lipid profiles, including triglycerides. The proposed mechanisms are attributed to the berry's rich content of polyphenols, particularly anthocyanins, which exhibit strong antioxidant and anti-inflammatory properties.

In randomized controlled trials, such as those published in European Journal of Nutrition (2017) and Phytotherapy Research (2010), participants with metabolic syndrome or hyperlipidemia who consumed Aronia extract for 2-3 months showed statistically significant reductions in serum triglyceride levels compared to baseline or placebo groups. The magnitude of decrease, however, tended to be moderate. Animal studies have also consistently demonstrated triglyceride-lowering effects, likely mediated by improved lipid metabolism and reduced hepatic fat accumulation.

Despite these findings, the overall quality of evidence is moderate. Many studies are relatively small, of short duration, or use variable dosage forms of Aronia. Additionally, while the results are promising, they do not yet meet the level of evidence required for formal therapeutic recommendations. In summary, there is scientific support for the use of Aronia melanocarpa in reducing high triglycerides, but further large-scale, well-controlled trials are needed to confirm efficacy and determine optimal dosing.

More about Aronia melanocarpa
More about Triglycerides (high)

Other ingredients used for Triglycerides (high)

Other health conditions supported by Aronia melanocarpa

Products containing Aronia melanocarpa